Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for AcelRx Pharmaceuticals, Inc. (ACRX)

« Back to company index

ACRX Chatter Timeline

Stock Ticker for ACRX

Most Active Tweeters for ACRX

UserTweets
@StockWatchHQ 7
@soesbandits 5
@FlyOnTheWallHQ 4
@AmericanBanking 3
@SleekMoneycom 3

Recent Tweets for ACRX

FlyOnTheWallHQ @FlyOnTheWallHQ
Show Me The Money_Teva Pharmaceutical $TEVA Present AcelRx Pharmaceuticals $ACRX Stock And Cash Acquisition Offer I… https://t.co/DVNm0zqBYH
May 23rd 2019, 12:05pm
StockWatchHQ @StockWatchHQ
RT @StockWatchHQ: AcelRx Pharmaceuticals $ACRX To Confirm Merck $MRK Buyout Offer, Talks In Redwood City, CA https://t.co/4N1wbAXJAJ THE #…
May 23rd 2019, 9:05am
stocknewstimes @stocknewstimes
AcelRx Pharmaceuticals $ACRX Downgraded by Zacks Investment Research https://t.co/cEnA5oyzyN
May 23rd 2019, 6:05am
SleekMoneycom @SleekMoneycom
AcelRx Pharmaceuticals $ACRX Downgraded by Zacks Investment Research https://t.co/HyOcJLPtT2 #investing
May 23rd 2019, 6:05am
StockWatchHQ @StockWatchHQ
AcelRx Pharmaceuticals $ACRX To Confirm Merck $MRK Buyout Offer, Talks In Redwood City, CA https://t.co/4N1wbAXJAJ… https://t.co/NTVmwmIwRL
May 22nd 2019, 10:05pm
WeekHerald @WeekHerald
AcelRx Pharmaceuticals $ACRX Cut to Hold at Zacks Investment Research https://t.co/CKtxBsseHy
May 22nd 2019, 4:05pm
ZolmaxNews @ZolmaxNews
AcelRx Pharmaceuticals Inc $ACRX Receives Average Rating of “Buy” from Brokerages https://t.co/aMRuqlypOJ
May 21st 2019, 3:05pm
medtechmd @medtechmd
RT @SolarMelt: $ACRX Preliminary Buy Signal just hit. Stochastic RSI says its oversold and ready to roll. This is a biotech specializing in…
May 21st 2019, 2:05pm
SolarMelt @SolarMelt
$ACRX Preliminary Buy Signal just hit. Stochastic RSI says its oversold and ready to roll. This is a biotech specia… https://t.co/1p78akwUyw
May 21st 2019, 12:05pm
ez_scans @ez_scans
$ACRX (( l3_lbbb ))=lower bband bounce
May 21st 2019, 9:05am
soesbandits @soesbandits
RT @KKing_Creative: AcelRx Pharmaceuticals $ACRX In Buyout Discussions With Medicines Co. $MDCO In New Jersey https://t.co/rhtRVIhPdf
May 21st 2019, 9:05am
TranscriptDaily @TranscriptDaily
AcelRx Pharmaceuticals $ACRX Upgraded at Zacks Investment Research https://t.co/JUHKWGfAhf
May 21st 2019, 2:05am
KKing_Creative @KKing_Creative
AcelRx Pharmaceuticals $ACRX In Buyout Discussions With Medicines Co. $MDCO In New Jersey https://t.co/rhtRVIhPdf
May 20th 2019, 10:05pm
soesbandits @soesbandits
RT @FlyOnTheWallHQ: Updated: Dr. Pamela Palmer Meeting With Pfizer $PFE In NYC As AcelRx Pharmaceuticals $ACRX Dsuvia Nears FDA Approval E…
May 20th 2019, 3:05pm
FlyOnTheWallHQ @FlyOnTheWallHQ
Updated: Dr. Pamela Palmer Meeting With Pfizer $PFE In NYC As AcelRx Pharmaceuticals $ACRX Dsuvia Nears FDA Approva… https://t.co/I7QBma8LPq
May 20th 2019, 3:05pm
FlyOnTheWallHQ @FlyOnTheWallHQ
Updated: Dr. Pamela Palmer Meeting With Pfizer $PFE In NYC As AcelRx Pharmaceuticals $ACRX Dsuvia Nears FDA Approva… https://t.co/L1o7tYMFZt
May 20th 2019, 3:05pm
StockRatingsHQ @StockRatingsHQ
RT @StockWatchHQ: AcelRx Pharmaceuticals $ACRX In Buyout Discussions With Medicines Co. $MDCO In New Jersey https://t.co/Kxeuaqr9in The #1…
May 19th 2019, 2:05pm
OlympiaReport @OlympiaReport
AcelRx Pharmaceuticals Inc $ACRX Receives $8.07 Consensus PT from Analysts https://t.co/Trji6CuYWO
May 19th 2019, 12:05pm
StockRatingsHQ @StockRatingsHQ
RT @StockWatchHQ: Dr. Pamela Palmer Meeting With Pfizer $PFE In NYC As AcelRx Pharmaceuticals $ACRX Dsuvia Nears FDA Approval https://t.co/…
May 19th 2019, 12:05pm
TheMarketsDaily @TheMarketsDaily
AcelRx Pharmaceuticals $ACRX Rating Increased to Buy at Zacks Investment Research https://t.co/BoyR3R2YIs
May 19th 2019, 5:05am
soesbandits @soesbandits
RT @TickerReport: AcelRx Pharmaceuticals $ACRX Upgraded to “Buy” at Zacks Investment Research https://t.co/hkywcHSjww
May 18th 2019, 11:05pm
StockWatchHQ @StockWatchHQ
AcelRx Pharmaceuticals $ACRX In Buyout Discussions With Medicines Co. $MDCO In New Jersey https://t.co/Kxeuaqr9in… https://t.co/Vt19VQcJYC
May 18th 2019, 7:05pm
StockWatchHQ @StockWatchHQ
Dr. Pamela Palmer Meeting With Pfizer $PFE In NYC As AcelRx Pharmaceuticals $ACRX Dsuvia Nears FDA Approval… https://t.co/FbQkl1M6ms
May 18th 2019, 6:05pm
TickerReport @TickerReport
AcelRx Pharmaceuticals $ACRX Upgraded to “Buy” at Zacks Investment Research https://t.co/hkywcHSjww
May 18th 2019, 2:05pm
TopStockAlerts1 @TopStockAlerts1
$ACRX Closed strong. On watch for continuation!
May 18th 2019, 11:05am
StockWatchHQ @StockWatchHQ
RT @FlyOnTheWallHQ: Dr. Pamela Palmer Meeting With Pfizer $PFE In NYC As AcelRx Pharmaceuticals $ACRX Dsuvia Nears FDA Approval https://t.c…
May 18th 2019, 9:05am
FlyOnTheWallHQ @FlyOnTheWallHQ
Dr. Pamela Palmer Meeting With Pfizer $PFE In NYC As AcelRx Pharmaceuticals $ACRX Dsuvia Nears FDA Approval… https://t.co/MMhIF2IDPj
May 17th 2019, 2:05pm
biotechw2019 @biotechw2019
$ACRX at top of the gap support. gap fill $2.60 ! https://t.co/QxVxQxOKlp
May 17th 2019, 7:05am
AmericanBanking @AmericanBanking
Weekly Investment Analysts’ Ratings Updates for AcelRx Pharmaceuticals $ACRX https://t.co/UuPPo9Z3M3 #stocks
May 16th 2019, 7:05pm
ConsumerFeed @ConsumerFeed
Weekly Investment Analysts’ Ratings Updates for AcelRx Pharmaceuticals $ACRX https://t.co/ezsga4UzW5
May 16th 2019, 7:05pm
soesbandits @soesbandits
RT @SeekingAlpha: $ACRX - After Years Of Development, AcelRx's Dsuvia Has Finally Generated Revenue https://t.co/EmWLnbm0Lw
May 16th 2019, 4:05pm
AmericanBanking @AmericanBanking
AcelRx Pharmaceuticals Inc $ACRX Given Consensus Rating of “Buy” by Brokerages https://t.co/zZkwfGrACH #stocks
May 16th 2019, 2:05pm
d_a_bravo7 @d_a_bravo7
2.15 is the bottom for $ACRX
May 16th 2019, 1:05pm
bocadmk @bocadmk
shorts positioning in front of secondary... $acrx
May 16th 2019, 10:05am
NewsToDesk @NewsToDesk
$ACRX: After Years Of Development, AcelRx’s Dsuvia Has Finally Generated …: https://t.co/K2dbWWDNFs
May 16th 2019, 8:05am
SeekingAlpha @SeekingAlpha
$ACRX - After Years Of Development, AcelRx's Dsuvia Has Finally Generated Revenue https://t.co/EmWLnbm0Lw
May 16th 2019, 8:05am
topticktrader @topticktrader
RT @TradeHawk: $ACRX Buzzfeed files a lawsuit against the FDA to try and force the FDA to release Freedom of Information Act records relate…
May 15th 2019, 6:05pm
TraderTexMex @TraderTexMex
This story could get ugly in the future. $ACRX https://t.co/TyEzstcL4v
May 15th 2019, 5:05pm
TradeHawk @TradeHawk
$ACRX Buzzfeed files a lawsuit against the FDA to try and force the FDA to release Freedom of Information Act recor… https://t.co/QB5aBW4HvB
May 15th 2019, 5:05pm
StockWatchHQ @StockWatchHQ
RT @StockWatchHQ: As Ye Sow, So Shall Ye Reap_AcelRx Pharmaceuticals $ACRX Will Announce Terms Of Agreement Reached in Significant Partners…
May 15th 2019, 10:05am
stocknewstimes @stocknewstimes
B. Riley Comments on AcelRx Pharmaceuticals Inc’s FY2019 Earnings $ACRX https://t.co/F1y9y3tQnt
May 15th 2019, 4:05am
SleekMoneycom @SleekMoneycom
B. Riley Comments on AcelRx Pharmaceuticals Inc’s FY2019 Earnings $ACRX https://t.co/ixaZMqoWVX #investing
May 15th 2019, 4:05am
StockWatchHQ @StockWatchHQ
As Ye Sow, So Shall Ye Reap_AcelRx Pharmaceuticals $ACRX Will Announce Terms Of Agreement Reached in Significant Pa… https://t.co/b5FS7qdzHi
May 14th 2019, 11:05pm
soesbandits @soesbandits
RT @TheMarketsDaily: LADENBURG THALM/SH SH Reiterates “Buy” Rating for AcelRx Pharmaceuticals $ACRX https://t.co/ZNxJy8ain4
May 14th 2019, 4:05pm
Stock_News_Now @Stock_News_Now
$ACRX: New SEC Filing for ACRX: Form DEF 14A (No. 0001437749-19-009718): https://t.co/thKWNHq4P1
May 14th 2019, 6:05am
Allstocknews @Allstocknews
$ACRX New Form DEFA14A for AcelRx Pharmaceuticals From our Stock News Alerts App
May 14th 2019, 6:05am
StockTexts @StockTexts
$ACRX AcelRx Pharmaceuticals, Inc. SEC Filing: Form DEF 14A https://t.co/Ss67PmQQu9
May 14th 2019, 6:05am
Allstocknews @Allstocknews
$ACRX New Form DEF 14A for AcelRx Pharmaceuticals From our Stock News Alerts App
May 14th 2019, 6:05am
ExecPayOrg @ExecPayOrg
AcelRx Pharmaceuticals CEO Vincent Angotti's 2018 pay falls 26% to $1.7M https://t.co/6EGj0mOmIc $ACRX #execpay
May 14th 2019, 6:05am
macondailynews @macondailynews
B. Riley Comments on AcelRx Pharmaceuticals Inc’s FY2019 Earnings $ACRX https://t.co/CrzkApxfH0
May 14th 2019, 3:05am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.